ArticleFrontiers in cardiovascular medicine2026
Can indwelling pleural catheters provide additional benefits in elderly heart failure patients with pleural effusion? A real-world retrospective multicenter analysis.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pleural effusion (PE) is a common presentation in patients with congestive heart failure. Evidence on the necessity of therapeutic pleural drainage (PD) remains conflicting, highlighting a gap in optimal care for patients. This study aimed to compare standard diuretic therapy (SDT) within guideline-directed medical therapy (GDMT) versus PD in elderly acute heart failure (AHF) patients with moderate PE. Methods and results: We conducted a real-world multicenter, retrospective observational cohort study in China. We screened patients within the age range of 60-100 years who were admitted to hospital with AHF and moderate pleural effusions between January 2014 and January 2024. Patients were divided into two groups: the PD group and the GDMT group. The primary and secondary endpoints were time to spontaneous pleurodesis and readmission rate, respectively. Of the 936 elderly AHF patients with moderate pleural effusion who were screened, 514 of them were included in final analysis. Time to spontaneous pleurodesis and time to discharge were shorter in the GDMT group than in the PD group ( Conclusion: SDT within GDMT yielded comparable outcomes to pleural drainage in elderly AHF patients with moderate PE, with respect to effusion resolution and hospital length of stay, without increased risk of worsening renal function or electrolyte imbalance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.